63 results
Page 3 of 4
8-K
EX-99.1
kk54bo90ak
6 May 20
Axcella Announces Positive Top-Line Data from AXA1125-003 Clinical Study Showing Multifactorial Activity in Adult Subjects with NAFLD
8:09am
DEFA14A
wxxia32qzem
3 Apr 20
Additional proxy soliciting materials
4:19pm
DEF 14A
ehm e7mrr71u0
3 Apr 20
Definitive proxy
4:15pm
DRS
1w83k9 e36zrsk73e
3 Apr 20
Draft registration statement
12:00am
10-K
saf4 e9m8ct4jov
23 Mar 20
Annual report
4:12pm
8-K
EX-10.1
cb80opw
25 Nov 19
Axcella Strengthens Executive Team with Key Addition and Promotion
8:11am
10-Q
smcz7t00gcqj
20 Jun 19
Quarterly report
5:03pm
424B4
gec plq7n
9 May 19
Prospectus supplement with pricing info
4:29pm
S-1/A
EX-1.1
k5xuaov
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
n1a1ppspe82ou6snd
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.12
9v8 5s2bz5ii2uj
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.2
peadpurm b4l
30 Apr 19
IPO registration (amended)
6:06am
S-1/A
EX-10.10
avkv0f
30 Apr 19
IPO registration (amended)
6:06am
CORRESP
lt2fikk 13xt
24 Apr 19
Correspondence with SEC
12:00am
S-1
EX-4.2
3utsukk34luxvn1us
12 Apr 19
IPO registration
7:02am